NCT Number: NCT00174317
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
To determine if celecoxib 200 mg once daily is as effective as diclofenac 50 mg three times daily in the treatment of pain symptoms associated with osteoarthritis of the hip
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Pfizer Investigational Site, Aston Clinton, Bucks, United Kingdom
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosed with osteoarthritis of hip and requiring joint replacement
- Eligible for chronic therapy with an NSAID
Exclusion criteria
- Hip surgery anticipated within 8 calendar weeks after first visit
- Active gastrointestinal disease or recent diagnosis of gastrointestinal ulceration (within 60 days of first visit)
Treatment and study plan
Diclofenac
DrugPrimary outcomes
-
Change in patient assessment of arthritis pain on walking VAS (Visual Analog Scale) as measured on a 0-100 mm scale at week 6 compared to baseline
Secondary outcomes
-
Change in patient assessment of arthritis pain on walking VAS (Visual Analog Scale) as measured on a 0-100 mm scale at week 12 compared to baseline.
-
Change in patients global assessment of arthritis between treatment groups.
Sponsors and collaborators
Lead sponsor
Pfizer
Industry
Registry information
Official study title
Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy
Important dates
- Study start
- 2003
- Study completion
- 2005
- First posted
- Sep 15, 2005
- Registry last updated
- Dec 5, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
NCT05530551
Arthritis, Joint Diseases
Aabenraa, Denmark
View Trial DetailsA Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
NCT03737149
Arthritis, Bronchial Diseases
Fremont, California, United States
View Trial DetailsPericapsular Nerve Group Block Added to Intra-articular Corticosteroid Injection in the Treatment of Hip Pain
NCT07427238
Arthritis, Hip Pain Chronic
Ankara, Turkey (Türkiye)
View Trial DetailsDevelopment of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions
NCT03102580
Arthritis, Joint Diseases
Chicago, Illinois, United States
View Trial Details